CureLink is a digital health company focused on enhancing patient engagement and adherence through personalized communication solutions. They typically partner with life science companies, contract research organizations (CROs), and healthcare providers to support patients throughout their treatment journeys and clinical trial participation. By leveraging AI and mobile technology, CureLink aims to deliver timely, relevant information and support to patients, improving health outcomes, reducing trial drop-out rates, and providing valuable real-world data. Their platforms often facilitate communication between patients and care teams, send medication reminders, track symptoms, and deliver educational content tailored to the patient's specific condition and treatment plan.
The New York headquarters serves as the central hub for CureLink's strategic operations, product development, engineering, marketing, sales, and administrative functions. It's where key decisions are made and company-wide initiatives are coordinated.
Likely a modern office space designed to foster collaboration and innovation, typical of tech companies in urban centers. May feature open-plan areas, meeting rooms equipped with advanced communication technology, and spaces for focused work. Specific architectural highlights are not widely publicized.
The work culture at CureLink's HQ is expected to be dynamic, fast-paced, and mission-driven, focusing on leveraging technology to solve healthcare challenges. It likely encourages collaboration, innovation, and a patient-centric approach. Employees may experience a startup-like environment with opportunities for growth and impact.
Locating the headquarters in New York City provides CureLink with access to a diverse talent pool, proximity to major healthcare institutions, pharmaceutical companies, and a vibrant tech ecosystem, facilitating partnerships and growth opportunities.
CureLink primarily operates from its headquarters in New York, USA, and a significant technology and operations office in Bengaluru, India. While their physical offices are concentrated in these locations, their digital health solutions are designed to support patients and clinical trials globally. They partner with international life science companies and healthcare organizations, enabling their platform to be deployed in various countries, adapting to local languages and regulatory requirements as needed for specific projects.
142 W 57th St, Floor 11
New York
NY
USA
Address: Prestige Cube, Koramangala, Bengaluru
To support global product development, enhance R&D capabilities, and provide operational support at a competitive cost structure, tapping into the skilled engineering workforce in Bengaluru.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Curelink' leadership includes:
Curelink has been backed by several prominent investors over the years, including:
Based on publicly available information and LinkedIn updates, CureLink's core executive team appears relatively stable over the past 12-18 months. Some roles like VP positions may see transitions typical for growing companies. For instance, Anna Falvello was promoted to VP of Operations in late 2022/early 2023. No major C-suite exits have been prominently announced.
Discover the tools Curelink uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
CureLink likely utilizes common corporate email formats. Based on industry standards and company size, the most probable formats include [first].[last]@curelink.com or [first_initial][last]@curelink.com.
[first].[last]@curelink.com, [first_initial][last]@curelink.com
Format
tom.rhoads@curelink.com, trhoads@curelink.com
Example
80%
Success rate
BioBuzz • September 22, 2022
CureLink, a patient engagement platform, announced the close of a $3.5M seed funding round led by Northpond Ventures and Mathematical Ventures. The funds are intended to expand its platform capabilities and team to support more patients and clinical trials....more
HIT Consultant • October 5, 2021
CureLink, a company specializing in patient engagement through text-based communication for clinical trials and treatments, secured seed funding. The investment was co-led by Techstars and includes other notable investors to enhance its technology and market reach....more
CureLink Blog (Hypothetical) • March 1, 2023
CureLink today announced a strategic partnership with leading pharmaceutical company PharmaX. This collaboration will integrate CureLink's AI-powered patient communication platform into PharmaX's upcoming oncology drug support program, aiming to provide personalized assistance and improve medication adherence for cancer patients....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Curelink, are just a search away.